Is It Possible for Neuralink to Fully Restore Body Functionality? Elon Musk Thinks So
Click to start listening
Synopsis
Elon Musk reveals that Neuralink could restore full body functionality, a potential game changer for individuals with spinal injuries. This breakthrough technology also aims to restore vision for the blind. Read on to learn more about Musk's ambitious vision and the future of neurotechnology.
Key Takeaways
- Neuralink aims to restore full body functionality for those with spinal cord injuries.
- The company is developing a brain chip called Blindsight to restore vision.
- Neuralink began human testing in 2022.
- The FDA has granted breakthrough designation to Blindsight.
- High-volume production is expected to commence in 2024.
New Delhi, Jan 3 (NationPress) On Saturday, billionaire Elon Musk stated that his brain-computer interface company, Neuralink, has the potential to restore full body functionality. This groundbreaking advancement targets the motor cortex, aiming to regain complete bodily functions for individuals with severed spinal cords.
“At this moment, I believe that the restoration of full body functionality is achievable through Neuralink,” shared the visionary behind Tesla and SpaceX in a post on the social media platform X.
“Neuralink essentially facilitates communication from the cortex, bypassing the damaged nerves in the neck or spine. From a physics perspective, it is feasible to physically restore full body functionality,” he elaborated in a video release.
The motor cortex technology was unveiled by Musk in 2022, with human testing commencing the same year.
The device comprises a chip that substitutes a small section of bone and connects to the brain through a network of thin, threaded electrodes. According to the company’s website, the N1 implant features 1,024 electrodes distributed across 64 threads.
In September, Neuralink revealed that it had successfully implanted its device in 12 patients.
Furthermore, on January 1, Musk’s California-based neurotechnology firm announced significant progress towards restoring vision, utilizing a brain implant designed for the visually impaired, including those blind from birth.
Neuralink's brain chip, known as Blindsight, received the “breakthrough device” designation from the US Food and Drug Administration (FDA) in September 2024, with plans for high-volume production set to begin this year.
“Neuralink aims to initiate large-scale production of brain-computer interface devices and transition to a highly automated surgical procedure by 2026. The device threads will penetrate the dura without requiring its removal—a significant advancement,” he noted on X.
Musk asserted that Blindsight could enable individuals who have lost both eyes to regain sight. He also mentioned that, if the visual cortex remains intact, the device could restore vision even in those who have been blind since birth.
Point of View
It's essential to recognize the significance of Elon Musk's claims regarding Neuralink's capabilities. While the potential to restore bodily functions and vision is groundbreaking, it is crucial to approach these advancements with caution and a critical understanding of the technology's implications for society. Our focus remains on providing accurate and insightful coverage, ensuring our audience is well-informed about such transformative developments.
NationPress
11/01/2026
Frequently Asked Questions
What is Neuralink's primary goal?
Neuralink aims to develop brain-computer interfaces that can restore bodily functions and potentially assist individuals with disabilities.
How does Neuralink plan to restore sight?
Neuralink's Blindsight device is designed to stimulate the visual cortex, enabling vision restoration even in individuals blind from birth.
When did Neuralink start human testing?
Neuralink began human testing in 2022 after unveiling their motor cortex technology.
What is the significance of the FDA's breakthrough designation?
The FDA's breakthrough designation for Blindsight highlights its potential to address serious medical needs and accelerates its development and review process.
When will Neuralink begin high-volume production?
Neuralink plans to start high-volume production of its brain-computer interface devices in 2024.
